Study S002392

A Preliminary Study to Explore the Efficacy of a GLP-1/FGF21 Dual Agonist (HEC88473) in Patients With Polycystic Ovary Syndrome (PCOS)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07616037
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2026-06
Primary completion: 2027-06
Lead sponsor: Shanghai Zhongshan Hospital
Conditions: PCOS (Polycystic Ovary Syndrome)
Interventions: DRUG:GLP-1/FGF21 dual agonist (HEC88473)
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Change From Baseline in Free Androgen Index Over 24 Weeks of Treatment [Baseline to Week 24 (assessed at scheduled follow-up visits).]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.